Cargando...
XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance
BACKGROUND: DNA repair pathways are used by cancer cells to overcome many standard anticancer treatments, causing therapy resistance. Here, we investigated the role of XRCC4-like factor (XLF), a core member of the non-homologous end joining (NHEJ) repair pathway, in chemoresistance in hepatocellular...
Gardado en:
| Publicado en: | BMC Cancer |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5437682/ https://ncbi.nlm.nih.gov/pubmed/28526069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3345-y |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|